Anavex Life Sciences Corp (AVXL)

[bb8675309]

Your response:

"The data shows that the non-wild type gene still responds to 2-73, just not as strongly. So you would still benefit from 2-73 either way. What is not currently known is can there be different dosing regimens that would increase the responses of the non-wild type gene people".

There are gene testing companies that will do whole genome testing. The one I found via Google wants $1000 for the whole genome testing and report.

Steady T. Thanks for your response. Yes. I know the people with the non - wild type gene still benefit. Was curious if any neurologist would know. $1000 for that information is not bad. Thanks